Cellectar Granted U.S. Patent for the Treatment of Various Cancers and Cancer Stem Cells with CLR 131 Pharmaceutical Investing
K2M Surpasses 100th Product Milestone with FDA Clearance and Launch of OZARK Cervical Plate Systems Medical Device Investing
Biogen Enters Exclusive Option Agreement to Acquire TMS’ Phase 2 Asset for Acute Stroke Pharmaceutical Investing
Chimerix Receives Orphan Drug Designation from the FDA for Brincidofovir for the Treatment of Smallpox Pharmaceutical Investing
FibroGen Announces Completion of Enrollment in U.S. Phase 3 Clinical Program for Roxadustat Pharmaceutical Investing
Ascendis Pharma Announces Orphan Drug Designation Granted for TransCon PTH as Treatment for Hypoparathyroidism Life Science Investing
RISE Life Science Corp. to Acquire California CBD Company Life Bloom Organics and Leading Cannabis Brand Strategy Agency Cultivate Kind Cannabis Investing News
BriaCell and BriaPro to Present Preclinical Anti-Cancer Activity and Immunotherapy Findings at SITC 2026Â
